Surprisingly, similar to the ACPA-positive RA group, the expression levels of CD3D, GZMK, and KLRB1 in the ACPA-negative RA group were significantly higher than those in the normal and OA groups (Figures 6A–C). This evidence concerns the gene GZMK and rheumatoid arthritis.